Whitney Ijem

Stock Analyst at Canaccord Genuity

(0)
# 4501
Out of 5,240 analysts
89
Total ratings
39.29%
Success rate
-13.80%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
Rhythm Pharmaceutica...
Maintains: Buy
80 80
54.37 47.14% 5 Nov 19, 2024
Rocket Pharmaceutica...
Maintains: Buy
39 39
10.75 262.79% 5 Nov 19, 2024
Intellia Therapeutic...
Maintains: Buy
90 90
9.86 812.78% 5 Nov 19, 2024
Taysha Gene Therapie...
Maintains: Strong Buy
6 8
1.65 384.85% 8 Nov 15, 2024
Passage Bio
Maintains: Buy
13 13
0.6 2066.67% 6 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
121 121
42.46 184.97% 7 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
148 150
120.97 24% 3 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 32
5.51 480.76% 4 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
361 408
419.49 -2.74% 7 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
366 384
250.03 53.58% 6 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
93 84
63.73 31.81% 8 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 16
1.47 988.44% 5 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
11 28
1.2 2233.33% 4 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
87 86
17.5 391.43% 4 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 30
n/a n/a 2 Jul 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
0.92 878.26% 1 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
260
n/a n/a 1 Feb 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
8 16
0.65 2361.54% 4 Jul 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
33 0
n/a n/a 2 Feb 26, 2018